These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18416454)

  • 21. Current gene therapy.
    Ferry N
    Curr Gene Ther; 2009 Apr; 9(2):61. PubMed ID: 19355863
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene therapy in the post-Gelsinger era.
    Smith L; Byers JF
    JONAS Healthc Law Ethics Regul; 2002 Dec; 4(4):104-10. PubMed ID: 12476067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.
    Rodriguez-Madoz JR; Zabala M; Alfaro M; Prieto J; Kramer MG; Smerdou C
    Hum Gene Ther; 2014 Feb; 25(2):132-43. PubMed ID: 24219025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors.
    Gerolami R; Uch R; Faivre J; Garcia S; Hardwigsen J; Cardoso J; Mathieu S; Bagnis C; Brechot C; Mannoni P
    J Hepatol; 2004 Feb; 40(2):291-7. PubMed ID: 14739101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver targeted gene therapy: Insights into emerging therapies.
    Moscoso CG; Steer CJ
    Drug Discov Today Technol; 2019 Dec; 34():9-19. PubMed ID: 33357766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond.
    Warren RS; Kirn DH
    Surg Oncol Clin N Am; 2002 Jul; 11(3):571-88, vi. PubMed ID: 12487057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy of hepatocellular carcinoma.
    Ruiz J; Mazzolini G; Sangro B; Qian C; Prieto J
    Dig Dis; 2001; 19(4):324-32. PubMed ID: 11935092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulating the gene-therapy revolution.
    Bender E
    Nature; 2018 Dec; 564(7735):S20-S22. PubMed ID: 30542185
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primates.
    Brunetti-Pierri N; Ng T; Iannitti DA; Palmer DJ; Beaudet AL; Finegold MJ; Carey KD; Cioffi WG; Ng P
    Hum Gene Ther; 2006 Apr; 17(4):391-404. PubMed ID: 16610927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method.
    Arad U; Zeira E; El-Latif MA; Mukherjee S; Mitchell L; Pappo O; Galun E; Oppenheim A
    Hum Gene Ther; 2005 Mar; 16(3):361-71. PubMed ID: 15812231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-directed gene transfer and application to therapy.
    Sandig V; Strauss M
    J Mol Med (Berl); 1996 Apr; 74(4):205-12. PubMed ID: 8740651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategy of liver-directed gene therapy: present status and future prospects.
    Shiratori Y; Kanai F; Ohashi M; Omata M
    Liver; 1999 Aug; 19(4):265-74. PubMed ID: 10459623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases.
    Berns KI; Srivastava A
    Gastroenterol Clin North Am; 2019 Jun; 48(2):319-330. PubMed ID: 31046978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gene and immunotherapy of liver diseases].
    Cantz T; Ott M; Kubicka S; Manns MP
    Internist (Berl); 2001 Oct; 42(10):1357-62, 1364-5. PubMed ID: 11688154
    [No Abstract]   [Full Text] [Related]  

  • 35. Liver-directed gene therapy.
    Nunes FA; Raper SE
    Med Clin North Am; 1996 Sep; 80(5):1201-13. PubMed ID: 8804381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene therapy of hepatic diseases: prospects for the new millennium.
    Shetty K; Wu GY; Wu CH
    Gut; 2000 Jan; 46(1):136-9. PubMed ID: 10601070
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic-Based Approaches to Inherited Metabolic Liver Diseases.
    Zabaleta N; Hommel M; Salas D; Gonzalez-Aseguinolaza G
    Hum Gene Ther; 2019 Oct; 30(10):1190-1203. PubMed ID: 31347416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for inherited diseases of liver metabolism.
    Piccolo P; Brunetti-Pierri N
    Hum Gene Ther; 2015 Apr; 26(4):186-92. PubMed ID: 25830689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.
    Zhou X; Yang XY; Popescu NC
    Int J Oncol; 2010 Apr; 36(4):999-1005. PubMed ID: 20198346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-directed gene therapy: prospects and problems.
    Strauss M
    Gene Ther; 1994 May; 1(3):156-64. PubMed ID: 7584076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.